California Public Employees Retirement System’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-127,435
| Closed | -$2.85M | – | 1166 |
|
|
2024
Q2 | $2.85M | Buy |
127,435
+811
| +0.6% | +$19.3K | ﹤0.01% | 1131 |
|
|
2024
Q1 | $3.48M | Hold |
126,624
| – | – | ﹤0.01% | 1133 |
|
|
2023
Q4 | $3.86M | Hold |
126,624
| – | – | ﹤0.01% | 1129 |
|
|
2023
Q3 | $4M | Hold |
126,624
| – | – | ﹤0.01% | 1114 |
|
|
2023
Q2 | $5.16M | Hold |
126,624
| – | – | ﹤0.01% | 1069 |
|
|
2023
Q1 | $4.72M | Sell |
126,624
-19,964
| -14% | -$783K | ﹤0.01% | 1093 |
|
|
2022
Q4 | $5.11M | Sell |
146,588
-10,409
| -7% | -$495K | ﹤0.01% | 1104 |
|
|
2022
Q3 | $8.79M | Buy |
156,997
+37,062
| +31% | +$2.3M | 0.01% | 931 |
|
|
2022
Q2 | $6.21M | Sell |
119,935
-28,766
| -19% | -$1.46M | 0.01% | 1029 |
|
|
2022
Q1 | $10.8M | Sell |
148,701
-4,885
| -3% | -$414K | 0.01% | 893 |
|
|
2021
Q4 | $18.2M | Buy |
153,586
+702
| +0.5% | +$87.9K | 0.01% | 703 |
|
|
2021
Q3 | $20.5M | Buy |
152,884
+9,125
| +6% | +$1.38M | 0.02% | 653 |
|
|
2021
Q2 | $23.3M | Buy |
143,759
+2,657
| +2% | +$207K | 0.02% | 626 |
|
|
2021
Q1 | $11.3M | Buy |
141,102
+26,868
| +24% | +$1.8M | 0.01% | 1001 |
|
|
2020
Q4 | $6.21M | Buy |
114,234
+852
| +0.8% | +$30.9K | ﹤0.01% | 1302 |
|
|
2020
Q3 | $2.25M | Buy |
113,382
+24,682
| +28% | +$515K | ﹤0.01% | 1769 |
|
|
2020
Q2 | $1.86M | Buy |
88,700
+9,900
| +13% | +$168K | ﹤0.01% | 1838 |
|
|
2020
Q1 | $964K | Buy |
78,800
+12,500
| +19% | +$168K | ﹤0.01% | 2036 |
|
|
2019
Q4 | $973K | Buy |
66,300
+54,900
| +482% | +$764K | ﹤0.01% | 2383 |
|
|
2019
Q3 | $152K | Buy |
+11,400
| New | +$182K | ﹤0.01% | 3007 |
|
|
2018
Q3 | – | Sell |
-10,638
| Closed | -$291K | – | 3297 |
|
|
2018
Q2 | $291K | Buy |
+10,638
| New | +$258K | ﹤0.01% | 2865 |
|
Other funds holding NTLA
AIM
DTC
NAMA
